$Moderna, Inc.(MRNA)$ Moderna's yearly sales for COVID vaccine are approximately 17 Billion USD. This is only Moderna's share of the market, not the total worldwide market.
The worldwide market for influenza is 6 Billion USD. If Moderna has a successful vaccine, then they will have sales of some portion of this 6 Billion USD. If this is correct, then the success of an influenza vaccine is not of major significance to the company's revenue.
When COVID is over, what will replace their current yearly sales of approximately 17 Billion USD??? And, what will be the profit margins, and R&D costs????
What is the potential market for their other products currently in the pipeline? What are the costs for development?
Are my figures correct?
精彩评论